KIMBERLY BRYANT: Open Payments
NPI 1235719584 · DEFUNIAK SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 25 payments from 8 companies in 2025. Trend: 2023 $747 · 2024 $782 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $136 |
| PFIZER INC. | 5 | $89 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Biosense Webster, Inc. | 1 | $35 |
| ABBVIE INC. | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $20 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, NURTEC ODT, CARTO 3, REXULTI, Ozempic, MOUNJARO, VRAYLAR.
Industry payments across FL — which companies pay providers there.
